SK278705B6 - 4-[(2-benzotiazolyl)metylamino] -alfa-[(3,4-difluó - Google Patents

4-[(2-benzotiazolyl)metylamino] -alfa-[(3,4-difluó Download PDF

Info

Publication number
SK278705B6
SK278705B6 SK512-92A SK51292A SK278705B6 SK 278705 B6 SK278705 B6 SK 278705B6 SK 51292 A SK51292 A SK 51292A SK 278705 B6 SK278705 B6 SK 278705B6
Authority
SK
Slovakia
Prior art keywords
formula
methyl
solution
compound
difluorophenoxy
Prior art date
Application number
SK512-92A
Other languages
English (en)
Slovak (sk)
Inventor
Raymond A. Stokbroekx
Gilbert A. J. Grauwels
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of SK278705B6 publication Critical patent/SK278705B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Paper (AREA)
SK512-92A 1991-02-25 1992-02-21 4-[(2-benzotiazolyl)metylamino] -alfa-[(3,4-difluó SK278705B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65964591A 1991-02-25 1991-02-25

Publications (1)

Publication Number Publication Date
SK278705B6 true SK278705B6 (sk) 1998-01-14

Family

ID=24646210

Family Applications (1)

Application Number Title Priority Date Filing Date
SK512-92A SK278705B6 (sk) 1991-02-25 1992-02-21 4-[(2-benzotiazolyl)metylamino] -alfa-[(3,4-difluó

Country Status (36)

Country Link
US (2) US5434168A (ru)
EP (2) EP0573473B1 (ru)
JP (1) JP2825652B2 (ru)
KR (1) KR0165901B1 (ru)
CN (3) CN1033454C (ru)
AT (1) ATE131478T1 (ru)
AU (1) AU649788B2 (ru)
BG (1) BG62332B1 (ru)
CA (1) CA2104000A1 (ru)
CY (1) CY1924A (ru)
CZ (1) CZ284705B6 (ru)
DE (1) DE69206787T2 (ru)
DK (1) DK0573473T3 (ru)
DZ (1) DZ1560A1 (ru)
EE (1) EE02983B1 (ru)
ES (1) ES2083737T3 (ru)
FI (1) FI933719A0 (ru)
GR (1) GR3018692T3 (ru)
HK (1) HK172296A (ru)
HU (2) HUT67695A (ru)
IE (1) IE69567B1 (ru)
IL (3) IL113837A (ru)
LV (1) LV11689B (ru)
MA (1) MA22447A1 (ru)
MX (1) MX9200777A (ru)
NO (1) NO300591B1 (ru)
NZ (2) NZ241592A (ru)
PL (1) PL168791B1 (ru)
RO (1) RO112959B1 (ru)
RU (2) RU2094434C1 (ru)
SK (1) SK278705B6 (ru)
TN (1) TNSN92017A1 (ru)
TW (1) TW218016B (ru)
WO (1) WO1992014731A1 (ru)
ZA (1) ZA921341B (ru)
ZW (1) ZW1992A1 (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol
TW282469B (ru) * 1993-06-11 1996-08-01 Janssen Pharmaceutica Nv
EP0785783A1 (en) * 1994-10-14 1997-07-30 Janssen Pharmaceutica N.V. Sabeluzole oral suspensions
US5744484A (en) * 1994-11-24 1998-04-28 Janssen Pharmaceutica, N.V. Lubeluzole intravenous solutions
EP0767675A4 (en) * 1995-04-10 1998-08-05 Baxter Int USE OF CROSS-LINKED HEMOGLOBIN IN THE TREATMENT OF SUBARACHNOIDAL BLEEDING
CN1200122A (zh) * 1995-10-25 1998-11-25 詹森药业有限公司 鲁贝洛唑n-氧化物
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
GB9815785D0 (en) * 1998-07-20 1998-09-16 Cerebrus Ltd Chemical compounds
ATE296814T1 (de) * 1999-05-12 2005-06-15 Neurosearch As Ionenkanal modulierende mittel

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963732A (en) * 1973-05-30 1976-06-15 Tiberio Bruzzese Process for preparing dihydroxydiphenylmethane derivatives
US4310658A (en) * 1980-06-18 1982-01-12 Allied Corporation Production of polyester thermally stabilized with an oxirane
US4861785A (en) * 1984-12-03 1989-08-29 Janssen Pharmaceutica N.V. Benzoxazol-and benzothiazolamine derivatives, useful as anti-anoxic agents
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
US4689330A (en) * 1985-04-15 1987-08-25 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4749702A (en) * 1985-04-15 1988-06-07 Janssen Pharmaceutica N. V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
US4717760A (en) * 1986-07-10 1988-01-05 The Dow Chemical Company Fluorinated tris-epoxides based on triphenyl methane
JPH0643426B2 (ja) * 1986-07-25 1994-06-08 東京田辺製薬株式会社 イミダゾ〔4,5−b〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol

Also Published As

Publication number Publication date
DE69206787T2 (de) 1996-06-05
EP0573473A1 (en) 1993-12-15
EP0573473B1 (en) 1995-12-13
HU211560A9 (en) 1995-12-28
RU95112519A (ru) 1997-04-20
US5434168A (en) 1995-07-18
CN1064865A (zh) 1992-09-30
FI933719A (fi) 1993-08-24
BG62332B1 (bg) 1999-08-31
MX9200777A (es) 1992-08-01
HU9302395D0 (en) 1993-11-29
CY1924A (en) 1997-03-07
NZ241592A (en) 1994-07-26
NZ248437A (en) 1994-07-26
MA22447A1 (fr) 1992-10-01
DK0573473T3 (da) 1996-01-29
ES2083737T3 (es) 1996-04-16
LV11689B (en) 1997-08-20
NO933010D0 (no) 1993-08-24
RU2094434C1 (ru) 1997-10-27
TNSN92017A1 (fr) 1993-06-08
KR0165901B1 (en) 1999-01-15
RU2106348C1 (ru) 1998-03-10
US5675027A (en) 1997-10-07
AU649788B2 (en) 1994-06-02
DZ1560A1 (fr) 2002-02-17
IL100952A (en) 1995-12-31
IL113837A0 (en) 1995-08-31
ATE131478T1 (de) 1995-12-15
CN1113437A (zh) 1995-12-20
CS51292A3 (en) 1992-09-16
HUT67695A (en) 1995-04-28
JP2825652B2 (ja) 1998-11-18
IL113837A (en) 1996-05-14
PL168791B1 (pl) 1996-04-30
ZW1992A1 (en) 1993-09-22
ZA921341B (en) 1993-08-24
GR3018692T3 (en) 1996-04-30
CN1043609C (zh) 1999-06-16
CZ284705B6 (cs) 1999-02-17
CN1033454C (zh) 1996-12-04
FI933719A0 (fi) 1993-08-24
HK172296A (en) 1996-09-20
IE920575A1 (en) 1992-08-26
DE69206787D1 (de) 1996-01-25
BG98068A (bg) 1994-06-30
NO300591B1 (no) 1997-06-23
EE02983B1 (et) 1997-04-15
AU1208592A (en) 1992-09-15
IL100952A0 (en) 1992-11-15
NO933010L (no) 1993-08-24
CA2104000A1 (en) 1992-08-26
EP0501552A1 (en) 1992-09-02
IE69567B1 (en) 1996-10-02
CN1117048A (zh) 1996-02-21
RO112959B1 (ro) 1998-02-27
TW218016B (ru) 1993-12-21
WO1992014731A1 (en) 1992-09-03
JPH06505012A (ja) 1994-06-09
LV11689A (lv) 1997-02-20

Similar Documents

Publication Publication Date Title
CA2206754C (en) Benzimidazole derivatives with antihistaminic activity
IL168118A (en) N-sulfonyl-4 methyleneamino-3-hydroxy-2-pyridones, methods for their preparation, pharmaceutical compositions comprising them and uses thereof
IE60885B1 (en) Anti-histaminic compositions containing N-heterocyclyl-4-piperidinamines
SK278705B6 (sk) 4-[(2-benzotiazolyl)metylamino] -alfa-[(3,4-difluó
KR100238562B1 (ko) 피페리딘 유도체 화합물
EP0316820B1 (en) Thiazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
CZ114099A3 (cs) 1,4-Disubstituované piperaziny
US20020035134A1 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists
CZ580390A3 (en) 6-ARYL-5,6-DIHYDRO-IMIDAZO£2,1-b|THIAZOLE DERIVATIVES, PROCESS OF THEIR PREPARATION, INTERMEDIATES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF
US5530011A (en) 4-[(2-benzothiazolyl)methylamino]-α-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol
CN112047962B (zh) 2H-噻唑并[3,2-b]-1,2,4-三嗪-3,7-二酮类衍生物及应用
WO2023288013A2 (en) Novel short-acting psychoactive compounds of the mdma class
PL193438B1 (pl) Pochodna 5-podstawionego-1,2,4-tiadiazolilu, jej zastosowanie i sposób wytwarzania, kompozycja farmaceutyczna, karbotioaminowa pochodna piperazyny i sposób jej wytwarzania
US20240092747A1 (en) Short-acting 3,4-methylenedioxymethamphetamine (mdma) analogs incorporating benzothiazole
KR20240046553A (ko) Sting 길항제로서의 소분자 우레아 유도체
JPH01110687A (ja) 2−オキサ−イソセフェム誘導体